Anaerobic Cause

The Prevalence, Comorbidity, Management, and Costs of Irritable Bowel Syndrome An Observational Study Using Routine Health Insurance Data by Prof. Dr. med. Winfried Häuser, Dr. med. Ursula Marschall, Prof. Dr. med. Peter Layer, and Dr. med. Thomas Grobe in issue 27–28/2019

This article (1) on concomitant diagnoses, examination services, and drug prescriptions does not even mention one of the most common and very important causes of irritable bowel syndrome, namely colonization of the large intestine with anaerobes. A corresponding adequate therapy with a few doses of clindamycin can do wonders here, allowing the patients to heal and saving payers from paying inappropriate and meaningless psychotherapeutic measures.

DOI: 10.3238/arztebl.2019.0755a

Dr. med. Walter Neussel

Wittlich
Germany

Conflict of interest statement

The author declares that no conflict of interest exists.

References

1. Häuser W, Marschall U, Layer P, Grobe T: The prevalence, comorbidity, management and costs of irritable bowel syndrome—an observational study using routine health insurance data. Dtsch Arztebl Int 2019; 116: 463–70